President and CEO: Alan Lewis.

Revenue: $18.1 million in 2009; $28.1 million in 2008, according to an SEC filing in February.

Net loss: $26.5 million in 2009; $9.8 million in 2008.

No. of local employees: 75.

Investors: Apposite Capital, Perseus-Soros BioPharmaceutical Fund, OrbiMed Advisors LLC, Forward Ventures and others.

Headquarters: Sorrento Valley.

Year founded: 2000.

Company description: Biotech that’s developing small-molecule, anti-cancer compounds.

Key factors for success: Pursuing clinical development of a lead drug product to treat a deadly form of leukemia found in older adults.

“In for a penny, in for a pound...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99